Features of the gut microbiome in mice with polygenic disorders of energy metabolism
Authors:
- Nadezhda S. NovikovaNNNadezhda S. Novikova
- Vladimir O. MurovetsVMVladimir O. Murovets
- Anastasia L. SeppASAnastasia L. Sepp
- Nikita S. GladyshevNGNikita S. Gladyshev
- Egor A. SozontovESEgor A. Sozontov
- Lyubov S. AlferovaLALyubov S. Alferova
- Vasily A. ZolotarevVZVasily A. Zolotarev
- Elena I. ErmolenkoEEElena I. Ermolenko
Open Access
- 30 June 2026
- journal article
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 103 (3) , 341-353
Abstract
Objective. To identify features of the gut microbiome using 16S rRNA gene sequencing in inbred KK.Cg-a/a (KK) mice and the KK.Cg-Ay/a (Ay) subline with metabolic syndrome (MetS) caused by different genetic disorders, compared to the C57BL/6J (B6) mouse line lacking manifestations of the pathology. Materials and methods. 3–4 months old male mice of three mouse lines were used: 1) KK mice with polygenic genomic disorders contributing to hyperglycemia, insulin resistance, and hyperinsulinemia; 2) the Ay substrain carrying an additional mutant dominant allele of the Agouti yellow coat color gene, exhibiting more severe MetS manifestations; 3) the B6 mouse line, not prone to obesity and diabetes (control group). All mice were of the same age (2 months) and sex (males) and received a normocaloric diet. Morphometry was performed for each animal, and biochemical parameters of blood serum were analyzed. PCR analysis of mRNA expression of neuropeptides and receptors in the hypothalamus was conducted. Mouse fecal samples were examined using 16S rRNA metagenomic analysis. Results. As previously shown, in male mice with genome-wide disorders on a normocaloric diet, obesity and alterations in carbohydrate and lipid metabolism developed, being more pronounced in the Ay group. Animals of the Ay substrain differed from other mice by greater body and liver weight, higher plasma glucose and leptin concentrations, and increased expression of Neuropeptide Y (NPY), Pro-opiomelanocortin (POMC), and Tas1r3. In all animals with MetS, the microbiome differed from the control group by a lower abundance of the family Muribaculaceae and the genus Akkermansia, and an increased percentage of the phylum Bacteroidota (genera Alistipes, Odoribacter, and Bacteroides). A distinctive feature of the Ay microbiome was an increased percentage of the families Enterobacteriaceae and Oscillospiraceae (Ruminococcaceae). Conclusion. Specific features of the gut microbiome characteristic of inbred animals with varying severities of energy metabolism disorders were identified. The models used can be employed to study the pathogenesis of MetS considering the role of microbiota, as well as to develop methods for predicting disease severity and correcting dysbiotic disturbances arising from energy metabolism disorders.Keywords
This publication has 47 references indexed in Scilit:
- Gut commensal Alistipes as a potential pathogenic factor in colorectal cancerDiscover Oncology, 2024
- Sweet Taste: From Reception to PerceptionNeuroscience and Behavioral Physiology, 2024
- Metabolic and Skeletal Characterization of the KK/Ay Mouse Model—A Polygenic Mutation Model of Obese Type 2 DiabetesCalcified Tissue International, 2024
- Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3Hepatology Communications, 2022
- Tumor tissue-specific bacterial biomarker panel for colorectal cancer: Bacteroides massiliensis, Alistipes species, Alistipes onderdonkii, Bifidobacterium pseudocatenulatum, Corynebacterium appendicisArchives of Microbiology, 2022
- A comparative study of microbial community and functions of type 2 diabetes mellitus patients with obesity and healthy peopleApplied Microbiology and Biotechnology, 2020
- Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabeticsEBioMedicine, 2019
- Microbiome and diabetes: Where are we now?Diabetes Research and Clinical Practice, 2018
- The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like Peptide 1 In VivoCell Metabolism, 2014
- Multidimensional Scaling by Optimizing Goodness of Fit to a Nonmetric HypothesisPsychometrika, 1964